However, these drugs are not a stand-alone solution
As with other agents that cause significant weight loss or gastrointestinal fluid losses, there are theoretical class-related risks that warrant attention, including gallbladder disease (cholelithiasis and cholecystitis have been reported with GLP-1 receptor agonists), and dehydration or acute kidney injury in the context of persistent vomiting or diarrhoea
This medication, administered through injection, helps people feel full for longer, helps regulate appetite, and reduces hunger and cravings
Most of the weight loss occurs in the first 6 months, with the remaining months showing smaller incremental reductions
Therefore, people have found that it has many extra-hypoglycemic effects, such as anti-inflammatory, anti-tumor, anti-aging and so on
Monitoring schedule When combining therapies, more frequent monitoring helps catch issues early: Month 1: Baseline labs including hormones (estradiol, progesterone, testosterone, FSH), metabolic panel, lipids, thyroid function, and HbA1c
